author-photo

Patrick Jedlowski

Mayo Clinic

18

Papers

518

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

2016 Blood
Show All
- Source
- Cite
- Save
Citations (128)
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.

2015 Blood
Show All
- Source
- Cite
- Save
Citations (15)
Cereblon binding molecules in multiple myeloma.

2015 Blood Reviews
Show All
- Source
- Cite
- Save
Citations (32)
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in -17p high risk disease

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (37)
Identification of FAM46C As a Multiple Myeloma Repressor

2015 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Targeted sequencing of relapsed/refractory myeloma patients identifies an enrichment of mutations in MAPK and Cereblon pathways

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Targeted Sequencing of Relapsed/Refractory Myeloma Patients Identifies an Enrichment of Mutations in Cereblon and MAPK Pathways

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M 3 P)

2015 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (36)
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma

2015 Haematologica
Show All
- Source
- Cite
- Save
Citations (20)
Ikaros Degradation Efficiency Correlates with Response of Multiple Myeloma (MM) Cells to IMiD Therapy and Is Blocked By Proteasome Inhibitors

2014 Blood
Show All
- Source
- Cite
- Save
Citations (2)